U.K. Centrum Ad Review Sets High Bar For Gender-Specific Claims
This article was originally published in The Tan Sheet
The U.K. Advertising Standards Agency says that while a television ad for Centrum multivitamins tailored to each gender did not make improper claims directly, the spot creates potential for consumers to believe it implies those claims.
You may also be interested in...
CSPI Expects Pfizer’s Centrum Claim Changes To Resonate Across Industry
Pfizer will discontinue advertising claims for Centrum Ultra Women’s and Silver Women’s multivitamin supplements for “breast health” and Centrum Ultra Men’s and Silver Ultra Men’s for “colon health.”
Bayer Relates Feeling ‘Sexy’ To Quick Relief For Allergies In Astepro Allergy Ad Campaign
Campaign featuring actress Meghann Fahy says "allergy sufferers can relieve their allergy symptoms and be more spontaneous in their romantic pursuits.” Ads launch two months after FDA granted tentative approval for two ANDAs for generic equivalents, indicating approval could come pending resolution of patent litigation.
US Infant Formula Supply Chain Strategy Delivered
FDA immediate actions include ensuring providers know they’re required to develop redundancy risk management plans, enhancing inspections of manufacturers, including by expanding and improving training for investigators, and expediting reviews of premarket submissions for new products.